Finding the Path to Biobank Sustainability Through Sound Business Planning.
作者信息
Henderson Marianne, Simeon-Dubach Daniel, Albert Monique
机构信息
1 National Cancer Institute, National Institutes of Health , Bethesda, Maryland.
2 medservice , Walchwil, Switzerland .
出版信息
Biopreserv Biobank. 2015 Dec;13(6):385-6. doi: 10.1089/bio.2015.29039.mh.
Abstract
摘要
相似文献
1
Finding the Path to Biobank Sustainability Through Sound Business Planning.
Biopreserv Biobank. 2015 Dec;13(6):385-6. doi: 10.1089/bio.2015.29039.mh.
2
Addressing the Challenge of Financial Sustainability in Biobanking.
Biopreserv Biobank. 2015 Dec;13(6):387-95. doi: 10.1089/bio.2015.29042.ahc.
3
Sustainability in Biobanking: Model of Biobank Graz.
Biopreserv Biobank. 2015 Dec;13(6):410-20. doi: 10.1089/bio.2015.0087.
4
The Biobank Economic Modeling Tool (BEMT): Online Financial Planning to Facilitate Biobank Sustainability.
Biopreserv Biobank. 2015 Dec;13(6):421-9. doi: 10.1089/bio.2015.0089.
5
Sustainability in a Hospital-Based Biobank and University-Based DNA Biorepository: Strategic Roadmaps.
Biopreserv Biobank. 2015 Dec;13(6):401-9. doi: 10.1089/bio.2015.0076.
6
Business Planning in Biobanking: How to Implement a Tool for Sustainability.
Biopreserv Biobank. 2017 Feb;15(1):46-56. doi: 10.1089/bio.2016.0045. Epub 2016 Nov 29.
7
Business Planning for a Campus-Wide Biobank.
Biopreserv Biobank. 2017 Feb;15(1):37-45. doi: 10.1089/bio.2016.0077. Epub 2017 Feb 2.
8
Nottingham Health Science Biobank: a sustainable bioresource.
Biopreserv Biobank. 2014 Oct;12(5):312-6. doi: 10.1089/bio.2014.0056.
9
Biobank Finances: A Socio-Economic Analysis and Review.
Biopreserv Biobank. 2015 Dec;13(6):435-51. doi: 10.1089/bio.2015.0030.
10
[Biobankonomics: the sustainability indicators of biobanks].
Med Sci (Paris). 2020 Mar;36(3):282-285. doi: 10.1051/medsci/2020043. Epub 2020 Mar 31.
引用本文的文献
1
Supporting Stewardship: Funding, Utilization, and Sustainability as Ethical Concerns in Networked Biobanking.
AJOB Empir Bioeth. 2025 Jan-Mar;16(1):42-51. doi: 10.1080/23294515.2024.2399533. Epub 2024 Sep 9.
2
Biobanking Legislation in Spain: Advancing or Undermining Its Ethical Values?
Biopreserv Biobank. 2024 Jun;22(3):242-247. doi: 10.1089/bio.2023.0107. Epub 2024 Jan 18.
3
Biobank and Pathology Facility: A Successful Combination.
J Biomol Tech. 2022 Feb 2;33(1). doi: 10.7171/3fc1f5fe.a423c94f. eCollection 2022 Apr 15.
4
Opportunities and Risks for Research Biobanks in the COVID-19 Era and Beyond.
Biopreserv Biobank. 2020 Dec;18(6):503-510. doi: 10.1089/bio.2020.0079. Epub 2020 Oct 8.
5
Transformation of the Taiwan Biobank 3.0: vertical and horizontal integration.
J Transl Med. 2020 Aug 6;18(1):304. doi: 10.1186/s12967-020-02451-4.
6
Assessing and measuring financial sustainability model of the Spanish HIV HGM BioBank.
J Transl Med. 2020 Jan 6;18(1):6. doi: 10.1186/s12967-019-02187-w.
7
Advancing Professionalization of Biobank Business Operations: Performance and Utilization.
Biopreserv Biobank. 2019 Jun;17(3):213-218. doi: 10.1089/bio.2019.0005.
8
Advancing Professionalization of Biobank Business Operations: A Worldwide Survey.
Biopreserv Biobank. 2019;17(1):71-75. doi: 10.1089/bio.2018.0079. Epub 2018 Nov 9.
9
Biospecimens and Biobanking in Global Health.
Clin Lab Med. 2018 Mar;38(1):183-207. doi: 10.1016/j.cll.2017.10.015. Epub 2017 Dec 24.
10
Trends in Biobanking Business Planning: Initial Results of a Survey of Biobankers.
Biopreserv Biobank. 2017 Feb;15(1):72-74. doi: 10.1089/bio.2016.0080. Epub 2016 Dec 12.
本文引用的文献
1
The Economics of Reproducibility in Preclinical Research.
PLoS Biol. 2015 Jun 9;13(6):e1002165. doi: 10.1371/journal.pbio.1002165. eCollection 2015 Jun.
2
Sustainability in biobanking.
Biopreserv Biobank. 2014 Oct;12(5):287-91. doi: 10.1089/bio.2014.1251. Epub 2014 Oct 14.
3
Drug development: Raise standards for preclinical cancer research.
Nature. 2012 Mar 28;483(7391):531-3. doi: 10.1038/483531a.
4
Believe it or not: how much can we rely on published data on potential drug targets?
Nat Rev Drug Discov. 2011 Aug 31;10(9):712. doi: 10.1038/nrd3439-c1.
Zotero 插件